Has Big Pharma hijacked the European health research budget?

The Lancet

Volumn 383, Issue 9924, 2014, Pages 1210-

  Galsworthy, Michael J ^a   Palumbo, Leonardo ^b   McKee, Martin ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b European Public Health Alliance   (Belgium)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; EUROPEAN UNION; HEALTH CARE COST; HEALTH SERVICES RESEARCH; HUMAN; LETTER; MEDICAL RESEARCH; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; BIOTECHNOLOGY; BUDGET; FUNDING; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; LEADERSHIP; NATIONAL HEALTH ORGANIZATION; POLICY;

BIOMEDICAL RESEARCH; BUDGETS; DRUG INDUSTRY; EUROPE; RESEARCH SUPPORT AS TOPIC;

EID: 84897578352     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60232-4     Document Type: Letter

References (7)

1. European Commission. EU JTIs and PPPs to receive extra funds. http:// horizon2020projects.com/policy-research/ eu-jtis-and-ppps-to-receive-extra- funds/ (accessed March 17, 2014).
2. European Federation of Pharmaceutical Industries and Associations. The Innovative Medicines Initiative (IMI)?Europe?s largest public-private- partnership encourages collaboration to tackle tough healthcare challenges. http://www.efpia.eu/topics/innovation/innovative-medicines-initiative (accessed March 17, 2014).
3. Wadman M. NIH director grilled over translational research centre. http://blogs. nature.com/news/2012/03/nih-directorgrilled- over-translational- research-center.html (accessed March 17, 2014).
4. European Commission. Health, Demographic Change and Wellbeing, http://ec.europa.eu/ programmes/horizon2020/en/h2020-section/ health-demographic-change-and-wellbeing (accessed March 17, 2014).
5. Walshe K, McKee M, McCarthy M, et al. Health systems and policy research in Europe: Horizon 2020. Lancet 2013; 382: 668-69.
6. Stuckler D, King L, Robinson H, McKee M. WHO?s budgetary allocations and burden of disease: a comparative analysis. Lancet 2008; 372: 1563-69.
7. European Federation of Pharmaceutical Industries and Associations. EFPIA Statement: European Parliament ITRE committee passes important milestone on the path to implementing IMI2.http://www. efpia.eu/mediaroom/138/43/EFPIAStatement- European-Parliament-ITREcommittee- passes-important-milestone-onthe- path-to-implementing-IMI2 (accessed March 17, 2014).